期刊文献+

CVVH和CVVHDF对脓毒症并发急性肾损伤患者不同溶质清除能力的影响 被引量:1

Effects of CVVH and CVVHDF on different solutes clearance in patients with sepsis complicated with acute kidney injury
下载PDF
导出
摘要 目的探讨持续性静脉-静脉血液滤过(CVVH)和持续性静脉-静脉血液透析滤过(CVVHDF)对脓毒症并发急性肾损伤(AKI)患者不同溶质清除能力的影响。方法回顾性分析2021年4月至2022年4月该院重症监护室收治的69例进行持续性肾脏替代治疗(CRRT)的脓毒症并发AKI患者的临床资料。根据不同滤过方式分为CVVH组(35例)和CVVHDF组(34例)。统计所有患者的预后情况,比较两组患者的临床资料、治疗前后的实验室指标及不同溶质的清除率。结果治疗30 d后,CVVH组7例患者死于脓毒症引起的多器官功能衰竭,2例患者死于心力衰竭,4例患者需继续进行CRRT,3例患者肾功能部分恢复。CVVHDF组6例患者死于脓毒症引起的多器官功能衰竭,3例患者死于心力衰竭,3例患者需继续进行CRRT,4例患者肾功能部分恢复。其余患者肾功能完全恢复并转回普通病房。CVVH组超滤速度、输注泵流速均快于CVVHDF组,差异均有统计学意义(P<0.05)。两组治疗前后预估肾小球滤过率、白细胞计数、C反应蛋白、肌酐、血尿素氮水平比较,差异均无统计学意义(P>0.05)。CVVH组肌酐清除率低于CVVHDF组,白细胞介素(IL)-8、IL-6清除率均高于CVVHDF组,差异均有统计学意义(P<0.05)。结论CVVHDF对肌酐的清除能力强于CVVH,而对IL-8、IL-6的清除能力弱于CVVH。 Objective To investigate the effects of continuous veno-venous hemofiltration(CVVH)and continuous veno-venous hemodiafiltration(CVVHDF)on different solutes clearance in patients with sepsis complicated with acute kidney injury(AKI).Methods The clinical data of 69 patients with sepsis complicated with AKI treated with continuous renal replacement therapy(CRRT)admitted to the intensive care unit of this hospital from April 2021 to April 2022 were retrospectively analyzed.The patients were divided into CVVH group(35 cases)and CVVHDF group(34 cases)according to different filtration methods.The prognosis of all patients was counted and the clinical data,laboratory indexes before and after treatment and clearance rates of different solutes were compared between the two groups.Results After 30 days of treatment,in CVVH group,7 patients died of multiple organ failure caused by sepsis,2 patients died of heart failure,4 patients still needed CRRT and 3 patients had partial recovery of renal function.In the CVVHDF group,6 patients died of multiple organ failure caused by sepsis,3 patients died of heart failure,3 patients still needed CRRT and 4 patients had partial recovery of renal function.The remaining patients had complete renal function recovery and were transferred back to the general ward.The ultrafiltration speed and the flow rate of infusion pump in CVVH group were faster than those in CVVHDF group,and the differences were statistically significant(P<0.05).There was no significant difference in estimated glomerular filtration rate,white blood cell count,the levels of C-reactive protein,creatinine and blood urea nitrogen between the two groups before and after treatment(P>0.05).The creatinine clearance rate in CVVH group was lower than that in CVVHDF group,and the clearance rates of interleukin(IL)-8 and IL-6 were higher than those in CVVHDF group,and the differences were statistically significant(P<0.05).Conclusion CVVHDF is superior to CVVH in the clearance of creatinine,but inferior to CVVH in the clearance of IL-8 and IL-6.
作者 姚成成 YAO Chengcheng(Department of Emergency Medicine,the Second Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou,Zhejiang 320000,China)
出处 《检验医学与临床》 CAS 2024年第8期1137-1140,1144,共5页 Laboratory Medicine and Clinic
关键词 持续性肾脏替代治疗 急性肾损伤 溶质清除能力 持续性静脉-静脉血液滤过 持续性静脉-静脉血液透析滤过 continuous renal replacement therapy acute kidney injury solute clearance continuous veno-venous hemofiltration continuous veno-venous hemodiafiltration
  • 相关文献

参考文献5

二级参考文献29

  • 1余晨,刘志红,陈朝红,龚德华,季大玺,黎磊石.连续性血液净化对血浆细胞因子水平的影响及其清除机制[J].肾脏病与透析肾移植杂志,2004,13(5):401-407. 被引量:68
  • 2常平,宫桔云,陶少华,胡艳群,封志纯.两种置换液配方在连续性血液净化中的效果比较[J].中国血液净化,2005,4(1):45-47. 被引量:23
  • 3蔡国龙,严静,虞意华,张昭才,龚仕金,戴海文,陈建国.高容量血液滤过对老年感染性休克合并MODS患者细胞因子的影响[J].中华急诊医学杂志,2006,15(1):57-60. 被引量:19
  • 4Ahrenholz P, Winkler RE, Ramlow W, et al. On-line hemodiafiltration with pie- and postdilutian: a comparison of efficacy [J]. IntJ Artif Organs, 1997, 20 (2): 81-90.
  • 5Cerd6 J, Ronco C. Modalities of continuous renal replacement therapy: technical and clinical considerations [ J ]. Semin Dial, 2009, 22 (2): 114-122.
  • 6Park JS, Kim GH, Kang CM, et al. Regional anticoagulation with citrate is superior to systemic anticoagulation with heparin in critically ill patients undergoing continuous venovenous hemodiafiltration [J]. Korean J Intern Med, 2011, 26 (1) : 68- 75.
  • 7Awdishu L, Bouchard J. How to optimize drug delivery in renal replacement therapy [J]. Semin Dial, 2011, 24 (2): 176-182.
  • 8Yamamoto T, Yasuno N, Katada S, et al. Proposal of a pharmacokinetically optimized dosage regimen of antibiotics in patients receiving continuous hemodiafiltration [ J ]. Antimicrob Agents Chemother, 2011,55 (12) : 5804-5812.
  • 9Pea F, Viale P, Pavan F, et al. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy [J]. Clin Pharmacokinet, 2007, 46 (12) : 997-1038.
  • 10Abe M, Okada K, Ikeda K, et al. Characterization of insulin adsorption behavior of dialyzer membranes used in hemodialysis [J]. ArtifOrgaus, 2011, 35 (4): 398-403.

共引文献16

同被引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部